Unknown

Dataset Information

0

Activation of Wnt/?-Catenin in Ewing Sarcoma Cells Antagonizes EWS/ETS Function and Promotes Phenotypic Transition to More Metastatic Cell States.


ABSTRACT: Ewing sarcomas are characterized by the presence of EWS/ETS fusion genes in the absence of other recurrent genetic alterations and mechanisms of tumor heterogeneity that contribute to disease progression remain unclear. Mutations in the Wnt/?-catenin pathway are rare in Ewing sarcoma but the Wnt pathway modulator LGR5 is often highly expressed, suggesting a potential role for the axis in tumor pathogenesis. We evaluated ?-catenin and LGR5 expression in Ewing sarcoma cell lines and tumors and noted marked intra- and inter-tumor heterogeneity. Tumors with evidence of active Wnt/?-catenin signaling were associated with increased incidence of tumor relapse and worse overall survival. Paradoxically, RNA sequencing revealed a marked antagonism of EWS/ETS transcriptional activity in Wnt/?-catenin-activated tumor cells. Consistent with this, Wnt/?-catenin-activated cells displayed a phenotype that was reminiscent of Ewing sarcoma cells with partial EWS/ETS loss of function. Specifically, activation of Wnt/?-catenin induced alterations to the actin cytoskeleton, acquisition of a migratory phenotype, and upregulation of EWS/ETS-repressed genes. Notably, activation of Wnt/?-catenin signaling led to marked induction of tenascin C (TNC), an established promoter of cancer metastasis, and an EWS/ETS-repressed target gene. Loss of TNC function in Ewing sarcoma cells profoundly inhibited their migratory and metastatic potential. Our studies reveal that heterogeneous activation of Wnt/?-catenin signaling in subpopulations of tumor cells contributes to phenotypic heterogeneity and disease progression in Ewing sarcoma. Significantly, this is mediated, at least in part, by inhibition of EWS/ETS fusion protein function that results in derepression of metastasis-associated gene programs. Cancer Res; 76(17); 5040-53. ©2016 AACR.

SUBMITTER: Pedersen EA 

PROVIDER: S-EPMC5010452 | biostudies-literature | 2016 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Activation of Wnt/β-Catenin in Ewing Sarcoma Cells Antagonizes EWS/ETS Function and Promotes Phenotypic Transition to More Metastatic Cell States.

Pedersen Elisabeth A EA   Menon Rajasree R   Bailey Kelly M KM   Thomas Dafydd G DG   Van Noord Raelene A RA   Tran Jenny J   Wang Hongwei H   Qu Ping Ping PP   Hoering Antje A   Fearon Eric R ER   Chugh Rashmi R   Lawlor Elizabeth R ER  

Cancer research 20160630 17


Ewing sarcomas are characterized by the presence of EWS/ETS fusion genes in the absence of other recurrent genetic alterations and mechanisms of tumor heterogeneity that contribute to disease progression remain unclear. Mutations in the Wnt/β-catenin pathway are rare in Ewing sarcoma but the Wnt pathway modulator LGR5 is often highly expressed, suggesting a potential role for the axis in tumor pathogenesis. We evaluated β-catenin and LGR5 expression in Ewing sarcoma cell lines and tumors and not  ...[more]

Similar Datasets

2016-11-30 | GSE75859 | GEO
| S-EPMC4811472 | biostudies-literature
| S-EPMC4155010 | biostudies-literature
| S-EPMC7406270 | biostudies-literature
| S-EPMC7072515 | biostudies-literature
2018-06-19 | GSE113604 | GEO
| S-EPMC3625903 | biostudies-other
| S-EPMC3056469 | biostudies-literature
| S-EPMC6353870 | biostudies-literature
| S-EPMC5930412 | biostudies-literature